Clinical Trial Update: Clinical Study on the Safety and Efficacy of CD7-Targeted Chimeric Antigen Receptor (CAR) Gene-Modified T Cells for the Treatment of CD7-Positive Hematological Malignancies [NA]

View source ↗

Summary

A clinical study is evaluating CD7-targeted CAR T cells for CD7-positive hematological malignancies. The trial status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cd7-positive Hematological Malignancies

Drugs mentioned

• CD7-targeted CAR T cells

Snippet

Sponsor: Donghua Zhang | Conditions: CD7-Positive Hematological Malignancies | NA | Status: NOT_YET_RECRUITING